The 4th European Society for Medical Oncology Asia Congress: bridging ultimate cancer care with real-world practice for the Asian practitioner in gynecological cancers

by Ngoi, Natalie YL, Tan, David SP
Published 2021

Exploiting replicative stress in gynecological cancers as a therapeutic strategy

by Ngoi, Natalie YL, Sundararajan, Vignesh, Tan, David SP
Published 2021

The Role of Molecular Tests for Adjuvant and Post-Surgical Treatment in Gynaecological Cancers

by Wijaya, Silvana Talisa, Ngoi, Natalie YL, Tan, David SP
Published 2021

Targeting the replication stress response through synthetic lethal strategies in cancer medicine

by Ngoi, Natalie YL, Pham, Melissa M, Tan, David SP, Yap, Timothy A
Published 2021

Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promises

by Pham, Melissa M, Ngoi, Natalie YL, Peng, Guang, Tan, David SP, Yap, Timothy A
Published 2021

The redox-senescence axis and its therapeutic targeting

by Ngoi, Natalie YL, Liew, Angeline QX, Chong, Stephen JF, Davids, Matthew S, Clement, Marie-Veronique, Pervaiz, Shazib
Published 2022

A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)

by Lee, Yong Jae, Lim, Myong Cheol, Kim, Byoung-Gie, Ngoi, Natalie YL, Choi, Chel Hun, Park, Sang-Yoon, Tan, David SP, Go, Yunjung, Lee, Jung-Yun
Published 2021

PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report

by Sachdeva, Manavi, Ngoi, Natalie YL, Lim, Diana, Poon, Michelle LM, Thian, Yee Liang, Lim, Yi Wan, Lim, Siew Eng, Tong, Pearl, Lum, Jeffrey HY, Ng, Joseph, Ilancheran, Arunachalam, Domingo, Efren J, Low, Jeffrey JH, Tan, David SP
Published 2021

A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma

by Heong, Valerie, Tan Tuan Zea, Miwa, Maiko, Ye, Jieru, Lim, Diana, Herrington, C Simon, Iida, Yasushi, Yano, Mitsutake, Yasuda, Masanori, Ngoi, Natalie YL, Wong, SB Justin, Okamoto, Aikou, Gourley, Charlie, Hasegawa, Kosei, Tan, David SP, Huang, Ruby YJ
Published 2021

A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)

by Ngoi, Natalie YL, Heong, Valerie, Ow, Samuel, Chay, Wen Yee, Kim, Hee Seung, Choi, Chel Hun, Goss, Geraldine, Goh, Jeffrey C, Tai, Bee Choo, Lim, Diana G, Kaliaperumal, Nivashini, Au, Veonice B, Connolly, John E, Kim, Jae-Weon, Friedlander, Michael, Kim, Kidong, Tan, David SP
Published 2020